Skip to content

Virtual Reality for Pediatric Palliative Care Team

Virtual Reality as a Tool to Promote Healthcare Providers Wellbeing in Pediatric Palliative Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06247618
Acronym
PPCVR
Enrollment
27
Registered
2024-02-08
Start date
2023-09-07
Completion date
2023-12-01
Last updated
2024-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Occupational Stress

Keywords

virtual reality, pediatric palliative care, anxiety, burnout

Brief summary

Is virtual reality a useful and usable tool to improve the psychological well-being of PPC operators? study primary obtv: assessment of occupational psychological well-being (divided into stress, depression, anxiety and risk of burnout) in the population of health professionals working in pediatric palliative care; verify if the virtual reality tool leads to an improvement change at the level of the investigated items (feasibility study). The treatment will have a duration of 4 weeks, with the execution of two sessions per week with the use of a viewer positioned on the head that allows users to navigate and interact in real time with a three-dimensional (3D) environment At time zero (T0), the participants will be administered, shortly before the application of virtual reality, the Mini-Z survey 2.0 questionnaires (the single item burnout question), Depression Anxiety Stress Scales 21 (DASS-21), and a demographic questionnaire (gender, age, profession, shift work, years of work in PPCs). At the end of the compilation, two vision treatments will follow, which will take place three to four days apart. At time T1 (second week) and time T2 (third week) the DASS-21 will initially be administered followed by two weekly treatments with a visor. At the end (T3) the compilation of both tests (Mini-Z survey 2.0-the single item burnout question and the DASS-21) will be repeated following the last two applications of the viewer.

Interventions

DEVICEvisor

The treatment will have a duration of 4 weeks, with the execution of two sessions per week with the use of a viewer positioned on the head that allows users to navigate and interact in real time with a three-dimensional (3D) environment

Sponsors

Azienda Ospedaliera di Padova
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* work within the pediatric hospice of Padua * Absence of neurological pathologies * personnel who actively engage in membership/participation during all 4 weeks of the project

Exclusion criteria

* Subject do not sign written consent

Design outcomes

Primary

MeasureTime frameDescription
the psychological well-being of healthcare providers: risk of burnoutData collection lasted for four weeks\- Mini-Z Survey 2.0 (single-item): examines the risk of burnout among healthcare provides, particularly The Mini-Z responds to the goal of framing/identifying the burnout risk of workers on the pediatric palliative care team. , it was analysed frequencies and percentages of burnout risk based on the analysis criteria identifiable in Nagasaki et al. 2022 (1- In Total burnout; 2-Always has burnout symptoms the burnout symptoms I perceive are persistent; 3-Beginning of burnout; 4-Under stress; 5-Never felt in Burnout).
the psychological well-being of healthcare providers: anxiety, depression and stressData collection lasted for four weeks\- DASS-21(the Depression Anxiety Stress Scales 21) DASS-21 is a psychometric self-assessment test, derived from the Depression Anxiety Stress Scales \[22\], detecting three constructs: anxiety, depression and stress. It is measured by 21 items on a 4-point Likert scale (from 0-Not at all applies to me to 3-It applies a lot or most of the time to me). Cronbach's alpha of .80 is very good evidence of the high reliability of the tool's content.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026